Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy

The cancer testis antigen (CTA) lactate dehydrogenase C (LDHC) is a promising anticancer target with tumor‐specific expression and immunogenicity. Interrogation of breast cancer patient cohorts from The Cancer Genome Atlas (TCGA) and Molecular Taxonomy of Breast Cancer International Consortium (META...

Descripción completa

Detalles Bibliográficos
Autores principales: Naik, Adviti, Decock, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847988/
https://www.ncbi.nlm.nih.gov/pubmed/34050611
http://dx.doi.org/10.1002/1878-0261.13024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847988/
https://www.ncbi.nlm.nih.gov/pubmed/34050611
http://dx.doi.org/10.1002/1878-0261.13024

Ejemplares similares